News | September 12, 2011

New Study Finds Eating Chocolate Regularly Could Cut Cardiovascular Risk by One Third

September 12, 2011 — A new paper suggests that eating chocolate, among other lifestyle and diet choices, is a key factor in preventing heart disease. Oscar Franco, M.D., presented the paper at the European Society of Cardiology (ESC) Congress 2011.

The World Health Organization predicts that by 2030, nearly 23.6 million people will die from heart disease. A number of recent studies have shown that eating chocolate has a positive influence on human health due to its antioxidant and anti-inflammatory properties. This includes reducing blood pressure and improving insulin sensitivity (a stage in the development of diabetes).

However, the evidence about how eating chocolate affects your heart still remains unclear. So Franco and colleagues from the University of Cambridge carried out a large-scale review of existing evidence to evaluate chocolate’s effects on cardiovascular events like heart attack and stroke.

They analyzed the results of seven studies, involving more than 100,000 participants, on this topic. Differences in study design and quality were taken into account to minimize bias.

Five studies reported a beneficial link between higher levels of chocolate consumption and the risk of cardiovascular events. They also found the highest levels of chocolate consumption were associated with a 37 percent reduction in cardiovascular disease and a 29 percent reduction in stroke compared with lowest levels.

The studies did not differentiate between dark or milk chocolate and included consumption of chocolate bars, drinks, biscuits and desserts.

The authors say the findings need to be interpreted with caution, as commercially available chocolate is very calorific (around 500 calories for every 100 grams). As a result, eating too much could in itself lead to weight gain, risk of diabetes and heart disease.

They conclude that, given the health benefits of eating chocolate, initiatives to reduce current fat and sugar content in most chocolate products, without affecting the taste sensation, should be explored.

For more information: www.bmj.com

 


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now